DIVISLAB
2 deep-dives · 6 policy notes
What has moved DIVISLAB
3 dated calls from the policy coverage · 2 positive · 0 negative · 1 watch
- Watch2026-10-19inferred
An API and CRAMS supplier is insulated from trade margins entirely; the read-across is only through any volume response in the finished-dose oncology market
Policy Pulse - Ministries & Regulators - 19 Oct 2026 - Positive2026-10-01inferred
More early-stage Indian discovery translates into more process development, analytical and manufacturing work flowing into the listed CDMO and CRAMS complex over time ⚠️ inferred; the scheme names no company
Policy Pulse - Ministries & Regulators - 01 Oct 2026 - Positive2026-09-30
API and complex-manufacturing exposure benefits twice — as a supplier of ingredients to exempt categories and from the generic exclusion
Policy Pulse - Global Spillover - 30 Sep 2026
Deep-dive research
Policy Pulse — Ministries & Regulators — 21 Jul 2026
SEBI operationalises promoter share freeze for buybacks (Aug 1 deadline) — revived open market route; RBI FCNR flows at 0.72B; 230 products shortlisted for indigenisation (89B import substitution target). Impact: 🟢 BUY TCS, INFY, ITC, HDFCBANK (buyback), DIXON, HAL, BEL (indigenisation), SBI (FCNR)
Policy Pulse — Modi/India Govt — 21 Jul 2026
Nifty ends at 24,187.70 (-0.21%). TVS Motor (+51% PAT) & Bajaj Auto (+42% PAT) lead auto Q1; Govt shortlists 230 products for import substitution (89B); Maruti hikes prices ₹30K from Aug; SEBI operationalises buyback freeze. Crude at 9/bbl weighs. Impact: 🟢 BUY TVS, BAJAJ-AUTO, DIXON, HAL, TCS, ITC | 🔴 SELL INDIGO, SPICEJET, TITAN
Mentioned in Policy Pulse
Policy Pulse - Ministries & Regulators - 19 Oct 2026
NPPA capped trade margins on 137 cancer drugs at 30% from November 9, a margin reset that hits MEDPLUS and re-prices oncology-heavy portfolios like NATCOPHARM, while Jio's 30x anchor book keeps BSE and ANGELONE on the right side of the primary market.
Policy Pulse - Ministries & Regulators - 01 Oct 2026
The Finance Ministry cut the diesel and ATF export levy for a second fortnight, positive for IOC, BPCL and RELIANCE, as GST crossed Rs 2 lakh crore for a third month and the manufacturing PMI hit a seven-month high of 55.1. SEBI cleared corporate bond index futures for the NSE, the AMCA prototype RFP closed on 30 October with LT, BEL, BHARATFORG, BEML and DATAPATTNS named in the three shortlisted consortia while HAL did not qualify, and the rupee closed at 96.31 into a live RBI hike risk on October 7.
Policy Pulse - Global Spillover - 30 Sep 2026
The G20 Trade Ministerial opened in Milwaukee on steel excess capacity, MFN erosion and forced labour - the same ground as the Section 301 tariffs under challenge at the Court of International Trade - while core PCE at 3.0% cut October Fed hike odds from 71% to 35% and eased the front end. Saudi Arabia restarted the East-West pipeline and Yanbu loadings, Gulf exports recovered to 23.3 mbpd with Brent near $103, and India kept 0% Section 232 tariffs on specialty drugs, supporting SUNPHARMA and DRREDDY.
Policy Pulse — Ministries & Regulators — 29 Jul 2026
SEBI PMS overhaul consultation paper. Market rallies +889 pts led by IT (+2.55%), HUL (+4.70%), INFY (+4.50%). NSE removes Exide from F&O.
Policy Pulse — Global — 17 Jul 2026
Strait of Hormuz escalation: buy XOM, CVX, OXY, EOG; sell DAL, UAL, AAL, CCL, RCL. Section 301 deadline Jul 20: buy WMT, TGT, COST if Section 122 lapses; sell TCS, INFY, WIPRO, SUNPHARMA if 12.5% tariff hits.
Policy Pulse — Modi — 13 Jul 2026
India rejects rushed US trade deal — demands tariff edge over China. Risk of steeper tariffs later this month. IT (TCS, INFY) and textiles (WELSPUN, TRIDENT) exposed. HAL receives 7th GE engine — Tejas Mk1A programme gains momentum.